Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
Jain MR, Giri SR, Bhoi B, Trivedi C, Rath A, Rathod R, Ranvir R, Kadam S, Patel H, Swain P, Roy SS, Das N, Karmakar E, Wahli W, Patel PR.
Jain MR, et al. Among authors: giri sr.
Liver Int. 2018 Jun;38(6):1084-1094. doi: 10.1111/liv.13634. Epub 2017 Dec 14.
Liver Int. 2018.
PMID: 29164820
Free PMC article.